-+ 0.00%
-+ 0.00%
-+ 0.00%

Aquestive Therapeutics Affirms FY2026 Sales Guidance of $46.000M-$50.000M vs $51.040M Est

Benzinga·11/03/2026 21:03:17
语音播报
Aquestive Therapeutics (NASDAQ:AQST) affirms FY2026 sales outlook from $46.000 million-$50.000 million to $46.000 million-$50.000 million vs $51.040 million estimate.